Knights of Columbus Asset Advisors’s TG Therapeutics TGTX Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-24,997	Closed	-$376K	–	382
2023 Q1	$376K	Hold	24,997	–	–	0.04%	276
2022 Q4	$296K	Sell	24,997 -20,316	-45%	-$147K	0.03%	277
2022 Q3	$268K	Buy	45,313 +5,638	+14%	+$37K	0.03%	266
2022 Q2	$169K	Hold	39,675	–	–	0.02%	283
2022 Q1	$377K	Buy	39,675 +428	+1%	+$4.95K	0.03%	259
2021 Q4	$746K	Buy	39,247 +695	+2%	+$18K	0.06%	236
2021 Q3	$1.28M	Buy	38,552 +205	+0.5%	+$6.34K	0.11%	219
2021 Q2	$1.49M	Buy	38,347 +233	+0.6%	+$9.15K	0.14%	218
2021 Q1	$1.84M	Buy	38,114 +8,172	+27%	+$393K	0.18%	191
2020 Q4	$1.56M	Buy	+29,942	New	+$1.01M	0.17%	222

Other funds holding TGTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Knights of Columbus Asset Advisors's TGTX Position: Q2 2023 in Review

Knights of Columbus Asset Advisors sold out of TG Therapeutics (TGTX) in Q2 2023, closing a stake of 24,997 shares — an estimated $376K sold.

Knights of Columbus Asset Advisors first reported a position in TGTX in Q4 2020 and held it in 10 quarters. The position peaked at $1.84M in Q1 2021. 244 funds tracked by Wall St. Rank hold TGTX as of Q2 2023.

Knights of Columbus Asset Advisors reported no remaining TG Therapeutics position as of Q2 2023 after selling out during the quarter.
Knights of Columbus Asset Advisors sold 24,997 TG Therapeutics shares in Q2 2023, an estimated $376K.
Knights of Columbus Asset Advisors first reported a position in TG Therapeutics in Q4 2020 and held it in 10 quarters.
Knights of Columbus Asset Advisors's TG Therapeutics position peaked at $1.84M in Q1 2021.
244 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2023.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.